---
title: Proteomics International Laboratories Ltd PromarkerD US Reimbursement Price & Aus Regulatory Decision – MarketScreener
description: Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce a major milestone in the commercialisation of its predictive test for diabetic kidney disease, PromarkerD, with the US Centers for Medicare & Medicaid Services (CMS) setting a national reimbursement price for the test in the United States.
---

[News & Media ](https://www.proteomics.com.au/news-media)

# [Proteomics International Laboratories Ltd PromarkerD US Reimbursement Price & Aus Regulatory Decision – MarketScreener](https://www.proteomics.com.au/news-media/proteomics-international-laboratories-ltd-promarkerd-us-reimbursement-price-aus-regulatory-decision-marketscreener)

 Written by [Proteomics](https://www.proteomics.com.au/news-media/author/proteomics) | Sep 27, 2023 4:15:00 PM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce a major milestone in the commercialisation of its predictive test for diabetic kidney disease, PromarkerD, with the US Centers for Medicare & Medicaid Services (CMS) setting a national reimbursement price for the test in the United States.

Article: [Proteomics International Laboratories Ltd PromarkerD US Reimbursement Price & Aus Regulatory Decision](https://www.marketscreener.com/quote/stock/PROTEOMICS-INTERNATIONAL-18474992/news/Proteomics-International-Laboratories-Ltd-PromarkerD-US-Reimbursement-Price-Aus-Regulatory-Decisi-44947463/)

[View full post](https://www.proteomics.com.au/news-media/proteomics-international-laboratories-ltd-promarkerd-us-reimbursement-price-aus-regulatory-decision-marketscreener)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Proteomics"
  },
  "dateModified" : "2025-08-04T12:14:13.298Z",
  "datePublished" : "2023-09-27T16:15:00Z",
  "headline" : "Proteomics International Laboratories Ltd PromarkerD US Reimbursement Price & Aus Regulatory Decision – MarketScreener",
  "image" : {
    "@type" : "ImageObject",
    "height" : 60,
    "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
    "width" : 60
  },
  "mainEntityOfPage" : "https://www.proteomics.com.au/news-media/proteomics-international-laboratories-ltd-promarkerd-us-reimbursement-price-aus-regulatory-decision-marketscreener",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News & Media"
  }
}
```